Mark Kakas
Legal Operations Lead at UCB | Brussels Metropolitan Area, Belgium
Mark Kakas’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Mark Kakas currently functions as the Legal Operations Lead at UCB, where he oversees legal department efficiency for a pharmaceutical organization dedicated to treating severe central nervous system and immunological conditions. He completed his academic training at Central European University while managing compliance and contractual workflows from the Brussels Metropolitan Area. His operational leadership concentrates on streamlining legal processes to support the company’s broader commercial and therapeutic innovation goals.
BEST APPROACH TO REACH Mark Kakas
Contact him directly via his high-confidence personal email address with a concise, research-backed message detailing how your service specifically reduces legal operational friction for pharmaceutical contract management teams.
Legal Operations Lead at UCB in January 2025 - Present
Head of Government Affairs & Business Development at ACQUIS in May 2024 - December 2024
Senior Policy Advisor & Business Manager at ACQUIS in August 2022 - May 2024
General Manager at gunnercooke LegalTech in March 2022 - July 2023
General Manager at LEXITUP in January 2020 - August 2022
Consultant at Explico CEE in March 2017 - August 2022
Junior Associate at OPL in March 2017 - May 2019
Intern at OPL Attorneys in June 2016 - March 2017
Central European University, Master of Science - MS, August 2026
University of Pécs
University of Pécs, Bachelor's degree
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.
Discover more about UCB
Head of Business Excellence, Patient Supply at UCB
Sr Director, Head of Business Excellence at UCB
(September 2024 – Present)
Senior Project Leader
Senior Project Leader at UCB
(June 2025 – Present)
Head of Clinical Supply Chain
Head of Clinical Supply Chain at UCB
(September 2024 – Present)
Global TA&L Launch Excellence Lead
Global TA&L Launch Excellence Lead at UCB
(June 2022 – Present)
Head of Safety Histology | PhD
Senior Scientist at UCB
(October 2020 – Present)
Gene Therapy Process Engineering Lead
Gene Therapy Process Engineering Lead at UCB
(September 2024 – Present)
What is Mark Kakas email address?
Email Mark Kakas at [email protected] and [email protected]. This email is the most updated Mark Kakas's email found in 2026.
How to contact Mark Kakas?
To contact Mark Kakas send an email to [email protected] or [email protected]. (updated on November 07, 2025)
What company does Mark Kakas work for?
Mark Kakas works for UCB.
What is Mark Kakas's role at UCB?
Mark Kakas is Legal Operations Lead
What industry does Mark Kakas work in?
Mark Kakas works in the Management Consulting industry.
